메뉴 건너뛰기




Volumn 3, Issue 1, 1997, Pages 37-44

Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A

Author keywords

immunization; MART 1; melanoma

Indexed keywords

TUMOR ANTIGEN;

EID: 0030996710     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (300)

References (24)
  • 1
    • 0028316911 scopus 로고
    • Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
    • Kawakami Y, Eliyahu S, Delgado CH et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:3515-3519.
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 3515-3519
    • Kawakami, Y.1    Eliyahu, S.2    Delgado, C.H.3
  • 2
    • 0028303166 scopus 로고
    • A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
    • Coulie PG, Brichard V, Van Pel A et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas [see comments]. J Exp Med 1994;180:35-42.
    • (1994) J Exp Med , vol.180 , pp. 35-42
    • Coulie, P.G.1    Brichard, V.2    Van Pel, A.3
  • 3
    • 0027165558 scopus 로고
    • The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
    • Brichard V, Van Pel A, Wolfel T et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993;178:489-495.
    • (1993) J Exp Med , vol.178 , pp. 489-495
    • Brichard, V.1    Van Pel, A.2    Wolfel, T.3
  • 4
    • 0028298174 scopus 로고
    • Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection
    • Kawakami Y, Eliyahu S, Delgado CH et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994;91:6458-6462.
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 6458-6462
    • Kawakami, Y.1    Eliyahu, S.2    Delgado, C.H.3
  • 5
    • 0028607185 scopus 로고
    • A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3
    • van der Bruggen P, Bastin J, Gajewski T et al. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 1994;24:3038-3043.
    • (1994) Eur J Immunol , vol.24 , pp. 3038-3043
    • Van Der Bruggen, P.1    Bastin, J.2    Gajewski, T.3
  • 6
    • 0026057983 scopus 로고
    • Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide
    • Kast WM, Roux L, Curren J et al. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Nad Acad Sci USA 1991;88:2283-2287.
    • (1991) Proc Nad Acad Sci USA , vol.88 , pp. 2283-2287
    • Kast, W.M.1    Roux, L.2    Curren, J.3
  • 7
    • 0028876917 scopus 로고
    • Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans
    • Vitiello A, Ishioka G, Grey HM et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J Clin Invest 1995;95:341-349.
    • (1995) J Clin Invest , vol.95 , pp. 341-349
    • Vitiello, A.1    Ishioka, G.2    Grey, H.M.3
  • 8
    • 0028944328 scopus 로고
    • Influence of interleukin 12 on p53 peptide vaccination against established Meth a sarcoma
    • Noguchi Y, Richards EC, Chen YT et al. Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci USA 1995;92:2219-2223.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 2219-2223
    • Noguchi, Y.1    Richards, E.C.2    Chen, Y.T.3
  • 9
    • 0028302028 scopus 로고
    • Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
    • Kawakami Y, Eliyahu S, Sakaguchi K et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 1994;180:347-352.
    • (1994) J Exp Med , vol.180 , pp. 347-352
    • Kawakami, Y.1    Eliyahu, S.2    Sakaguchi, K.3
  • 10
    • 0028847576 scopus 로고
    • Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition
    • Stevens EJ, Jacknin L, Robbins PF et al. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. J Immunol 1995; 154:762-771.
    • (1995) J Immunol , vol.154 , pp. 762-771
    • Stevens, E.J.1    Jacknin, L.2    Robbins, P.F.3
  • 11
    • 0028942142 scopus 로고
    • Induction of tumor reactive CTL from peripheral blood and tumor infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1
    • Rivoltini L, Kawakami Y, Sakaguchi K et al. Induction of tumor reactive CTL from peripheral blood and tumor infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J Immunol 1995;154:2257-2265.
    • (1995) J Immunol , vol.154 , pp. 2257-2265
    • Rivoltini, L.1    Kawakami, Y.2    Sakaguchi, K.3
  • 12
    • 0028871599 scopus 로고
    • Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides
    • Salgaller ML, Afshar A, Marincola FM et al. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res 1995;55:4972-4979.
    • (1995) Cancer Res , vol.55 , pp. 4972-4979
    • Salgaller, M.L.1    Afshar, A.2    Marincola, F.M.3
  • 13
    • 0028239376 scopus 로고
    • Loss of HLA haplotype and B locus down-regulation in melanoma cell lines
    • Marincola FM, Shamamian P, Alexander RB et al. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J Immunol 1994;153:1225-1237.
    • (1994) J Immunol , vol.153 , pp. 1225-1237
    • Marincola, F.M.1    Shamamian, P.2    Alexander, R.B.3
  • 14
    • 0029968322 scopus 로고    scopus 로고
    • Binding and presentation of peptides derived from melanoma antigens MART-1 and gplOO by HLA-A2 subtypes: Implications for peptide-based immunotherapy
    • Rivoltini L, Loftus DJ, Barracchini KC et al. Binding and presentation of peptides derived from melanoma antigens MART-1 and gplOO by HLA-A2 subtypes: implications for peptide-based immunotherapy. J Immunol 1996;156:3882-3891.
    • (1996) J Immunol , vol.156 , pp. 3882-3891
    • Rivoltini, L.1    Loftus, D.J.2    Barracchini, K.C.3
  • 15
    • 0026576422 scopus 로고
    • HLA-A2 molecules in an antigen processing mutant cell contain signal sequence-derived peptides
    • Wei ML, Cresswell P. HLA-A2 molecules in an antigen processing mutant cell contain signal sequence-derived peptides. Nature 1992;356:443-446.
    • (1992) Nature , vol.356 , pp. 443-446
    • Wei, M.L.1    Cresswell, P.2
  • 16
    • 0029835516 scopus 로고    scopus 로고
    • Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: Evidence for in vivo priming by tumor cells
    • Marincola FM, Rivoltini L, Salgaller ML, Player M, Rosenberg SA. Differential anti-MART-1/MelanA CTL activity in peripheral blood of HLA-A2 melanoma patients in comparison to healthy donors: evidence for in vivo priming by tumor cells. J Immunother 1996;19:266-277.
    • (1996) J Immunother , vol.19 , pp. 266-277
    • Marincola, F.M.1    Rivoltini, L.2    Salgaller, M.L.3    Player, M.4    Rosenberg, S.A.5
  • 17
    • 0029061997 scopus 로고
    • Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen specific cytotoxic T lymphocytes
    • Rivoltini L, Barracchini KC, Viggiano V et al. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen specific cytotoxic T lymphocytes. Cancer Res 1995;55:3149-3157.
    • (1995) Cancer Res , vol.55 , pp. 3149-3157
    • Rivoltini, L.1    Barracchini, K.C.2    Viggiano, V.3
  • 18
    • 0026543967 scopus 로고
    • Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells
    • Coulie PG, Somville M, Lehmann F et al. Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells. Int J Cancer 1992;50:289-297.
    • (1992) Int J Cancer , vol.50 , pp. 289-297
    • Coulie, P.G.1    Somville, M.2    Lehmann, F.3
  • 19
    • 0025735051 scopus 로고
    • Specific release of granulocyte-macrophage colony stimulating factor, tumor necrosis factor-alpha and interferon gamma by human tumor infiltrating lymphocytes after autologous tumor stimulation
    • Schwartzentruber DJ, Topalian SL, Mancini M, Rosenberg SA. Specific release of granulocyte-macrophage colony stimulating factor, tumor necrosis factor-alpha and interferon gamma by human tumor infiltrating lymphocytes after autologous tumor stimulation. J Immunol 1991;146:3674-3681.
    • (1991) J Immunol , vol.146 , pp. 3674-3681
    • Schwartzentruber, D.J.1    Topalian, S.L.2    Mancini, M.3    Rosenberg, S.A.4
  • 20
    • 0026486222 scopus 로고
    • Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes
    • Miller MD, Gould-Fogerite S, Shen L et al. Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes. J Exp Med 1992;176:1739-1744.
    • (1992) J Exp Med , vol.176 , pp. 1739-1744
    • Miller, M.D.1    Gould-Fogerite, S.2    Shen, L.3
  • 21
    • 0029057043 scopus 로고
    • Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance
    • Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995;16:487-494.
    • (1995) Immunol Today , vol.16 , pp. 487-494
    • Ferrone, S.1    Marincola, F.M.2
  • 22
    • 8944254243 scopus 로고    scopus 로고
    • Analysis of expression of the melanoma associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in situ lesions
    • Marincola FM, Hijazi YM, Fetsch P et al. Analysis of expression of the melanoma associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in situ lesions. J Immunother 1996; 19:192-205.
    • (1996) J Immunother , vol.19 , pp. 192-205
    • Marincola, F.M.1    Hijazi, Y.M.2    Fetsch, P.3
  • 23
    • 0027968973 scopus 로고
    • Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice
    • Minev BR, McFarland BJ, Spiess PJ, Rosenberg SA, Restifo NP. Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice. Cancer Res 1994;54:4155-4161.
    • (1994) Cancer Res , vol.54 , pp. 4155-4161
    • Minev, B.R.1    McFarland, B.J.2    Spiess, P.J.3    Rosenberg, S.A.4    Restifo, N.P.5
  • 24
    • 0002145545 scopus 로고    scopus 로고
    • Recombinant anti-cancer vaccines
    • Restifo NP. Recombinant anti-cancer vaccines. Cancer J Sci Am 1996;2:16-18.
    • (1996) Cancer J Sci Am , vol.2 , pp. 16-18
    • Restifo, N.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.